Medical Equipment

Implantable Cardiac Rhythm Management Device Market 2025–2029: Tracking 6.9% CAGR Toward $23.15 Billion in Revenue

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the implantable cardiac rhythm management device market from 2025–2034 with trusted insights from The Business Research Company

How Will The Implantable Cardiac Rhythm Management Device Market Size Evolve Between Now And 2029?

The implantable cardiac rhythm management device market has experienced steady expansion in recent years. It is projected to increase from $17.06 billion in 2024 to $17.7 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.8%. This market’s historical growth can be linked to the aging population, increasing incidence of cardiac arrhythmias, awareness and education initiatives, healthcare infrastructure development, and rising healthcare expenditure.

The implantable cardiac rhythm management device market size is anticipated to demonstrate substantial growth in the upcoming years. It is predicted to expand to $23.15 billion by 2029, recording a compound annual growth rate (CAGR) of 6.9%. The expansion during the forecast period can be attributed to an increasing adoption of leadless devices, the implementation of remote patient monitoring, a heightened focus on heart failure management, growing uptake in emerging markets, and partnerships for research and development. Significant trends expected in the forecast period include the advent of bioresorbable technologies, the integration of artificial intelligence (AI), continuous technological advancements, the merging of remote monitoring with telemedicine, further progress in leadless pacemakers, wireless charging solutions, and enhanced power management systems.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10117&type=smp

Which Key Drivers Are Powering Growth In The Implantable Cardiac Rhythm Management Device Market?

The future expansion of the implantable cardiac rhythm management devices market is anticipated to be driven by the rising occurrence of cardiac disorders, which are conditions affecting the heart or its associated blood vessels. These devices are designed to assist individuals suffering from heart failure and diminished left ventricular function, enhancing systolic function through the resynchronization of heart contractions and the restoration of a regular heart rhythm during critical rapid ventricular arrhythmias. Consequently, the growing incidence of cardiac disorders will escalate the need for implantable cardiac rhythm management devices. As an illustration, figures from September 2024, released by the British Heart Foundation, a cardiovascular research charity in the UK, indicate that approximately 7.6 million people in the UK are impacted by heart and circulatory diseases, comprising roughly 4 million males and 3.6 million females. These conditions account for about 27% of all fatalities in the UK, translating to over 170,000 deaths each year, which is approximately 480 deaths daily, or one death every three minutes. This underscores how the increasing prevalence of cardiac disorders is propelling the expansion of the implantable cardiac rhythm management devices market.

How Is The Global Implantable Cardiac Rhythm Management Device Market Structured By Key Segments?

The implantable cardiac rhythm management devicemarket covered in this report is segmented –

1) By Device: Cardiac Resynchronization Therapy, Defibrillators, Pacemakers

2) By Application: Bradycardia, Tachycardia, Other Applications

3) By End-Use: Hospitals, Specialty Cardiac Centers, Other End-Uses

Subsegments:

1) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker), CRT-D (Defibrillator)

2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs), Subcutaneous Implantable Defibrillators (S-ICDs)

3) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers

What Future-Focused Trends Are Anticipated In The Implantable Cardiac Rhythm Management Device Market?

Technological advancement stands out as a key and increasingly popular trend in the implantable cardiac rhythm management devices market. Major companies within this market are actively developing new technologies to sustain their competitive position. For instance, in April 2022, Rhythm Management Group PLLC, a US-based company dedicated to ongoing cardiac device monitoring for implantable cardiac devices, introduced RhythmSynergy, a potent new technology platform. This platform utilizes machine learning to effectively deliver timely and pertinent clinical insights for patients remotely monitored, who have implantable cardiac devices alongside wearable devices such as blood pressure cuffs, scales, and glucometers. RhythmSynergy highlights essential information and streamlines review processes by combining clinical knowledge and machine learning technologies. Its sleek, secure architecture and powerful reporting features simplify the reviewing, sharing, and analysis of patient data.

Which Companies Hold A Competitive Edge In The Implantable Cardiac Rhythm Management Device Market?

Major companies operating in the implantable cardiac rhythm management device market include Schiller AG, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik Ltd., MicroPort Scientific Corporation, Abiomed Inc, Nihon Kohden Corporation, Japan Lifeline Co. Ltd., Lepu Medical Technology Co. Ltd., LivaNova PLC, Shenzhen Mindray Biomedical Electronics Co. Ltd, Progetti Srl, Edwards Lifesciences Corporation, Cardiac Science Corporation, Bardy Diagnostics Inc., Beijing Demax Medical Technology Co. Ltd, iRhythm Technologies Inc., Impulse Dynamics plc., VytronUS Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/implantable-cardiac-rhythm-management-device-global-market-report

Which Region Is Expected To Lead The Implantable Cardiac Rhythm Management Device Market In The Next Few Years?

North America was the largest region in the implantable cardiac rhythm management device market in 2024. The regions covered in the implantable cardiac rhythm management device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10117&type=smp

Browse Through More Reports Similar to the Global Implantable Cardiac Rhythm Management Device Market 2025, By The Business Research Company

Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795